Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)
Crossref DOI link: https://doi.org/10.1186/1546-0096-13-S1-P185
Published Online: 2015-09-28
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Trieste, L
Della Casa Alberighi, O
Turchetti, G
Pierotti, F
Accame, L
Lorenzoni, V
Frenkel, J
Gattorno, M
Quartier, P
Martini, A
Article History
First Online: 28 September 2015